Damora Therapeutics (DMRA) Other Non Operating Income (2019 - 2025)
Damora Therapeutics (DMRA) reported Other Non Operating Income of $3000.0 for Q4 2025, down 97.6% on a YoY basis from $125000.0 in Q4 2024, and up 115.79% quarter-over-quarter from -$19000.0 in Q3 2025.
Damora Therapeutics (DMRA) Other Non Operating Income (2019 - 2025) Analysis & Trends
Damora Therapeutics has reported Other Non Operating Income for 7 years, with the latest figure at $3000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income fell 97.6% year-over-year to $3000.0; the trailing twelve-month figure through Mar 2026 stood at -$78000.0 (down 1660.0% YoY), and the FY2025 full-year result was -$84000.0, down 566.67% from the prior year.
- Other Non Operating Income for Q4 2025 stood at $3000.0, up from -$19000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $208000.0 in Q3 2021, with the low at -$828000.0 in Q4 2022.
- Historically, Other Non Operating Income has averaged -$50650.0 across 5 years, with a median of -$12500.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Non Operating Income sank 2955.17% — and 2024, when it soared 351.85%.
- Damora Therapeutics' Other Non Operating Income stood at $29000.0 in 2021, then slumped by 2955.17% to -$828000.0 in 2022, then soared by 74.88% to -$208000.0 in 2023, then surged by 160.1% to $125000.0 in 2024, then tumbled by 97.6% to $3000.0 in 2025.
- The last three Other Non Operating Income figures came in at $3000.0 (Q4 2025), -$19000.0 (Q3 2025), and -$62000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Damora Therapeutics | 731.26 Mn | 528.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | -19,000.00 |
| Jun 30, 2025 | -62,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 125,000.00 |
| Sep 30, 2024 | -182,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | -208,000.00 |
| Sep 30, 2023 | -26,000.00 |
| Jun 30, 2023 | -27,000.00 |
| Mar 31, 2023 | 64,000.00 |
| Dec 31, 2022 | -828,000.00 |
| Sep 30, 2022 | -329,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | -60,000.00 |
| Dec 31, 2021 | 29,000.00 |
| Sep 30, 2021 | 208,000.00 |
| Jun 30, 2021 | -86,000.00 |
| Mar 31, 2021 | 168,000.00 |